This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prince, H. E. Articles by Lape-Nixon, M. Search for Related Content PubMed PubMed Citation Articles by Prince, H. E. Articles by Lape-Nixon, M.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1997, 217-222, Vol 4, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1- infected patients

HE Prince and M Lape-Nixon
MRL Reference Laboratory, Cypress, California 90630, USA.

Published studies suggest that mitogenic responses of lymphocytes can be reliably assessed by monitoring the expression of lymphocyte surface CD69 after 24 h of culture with the stimulant. We tested this hypothesis by determining the ability of lymphocyte CD69 expression to predict the outcome (normal or abnormal) of lymphocyte proliferative responses to anti-CD3 in a group of human immunodeficiency virus type 1 (HIV-1)-infected patients (n = 47). Cutoff values for defining normal and abnormal CD69 expression and proliferative ([3H]thymidine incorporation) responses were established with lymphocytes from healthy uninfected controls (n = 20). Lymphocytes from 29 HIV-infected patients exhibited an abnormal proliferative response, and those from 25 of the 29 also exhibited abnormal CD69 expression (sensitivity, 86.2%). Similarly, lymphocytes from 18 HIV-infected patients exhibited a normal proliferative response, and those from 16 of the 18 also exhibited normal CD69 expression (specificity, 88.9%). The predictive value of a normal CD69 result was 80%, and the predictive value of an abnormal CD69 result was 92.6%. These findings demonstrate that HIV-1-associated impairments in lymphocyte activation can be reliably detected by the rapid and nonradioactive CD69 expression assay.

This article has been cited by other articles:

• McCloskey, T. W., Haridas, V., Pontrelli, L., Pahwa, S. (2004). Response to Superantigen Stimulation in Peripheral Blood Mononuclear Cells from Children Perinatally Infected with Human Immunodeficiency Virus and Receiving Highly Active Antiretroviral Therapy. CVI 11: 957-962 [Abstract] [Full Text]  
• Mueller, Y. M., Bojczuk, P. M., Halstead, E. S., Kim, A. H. J., Witek, J., Altman, J. D., Katsikis, P. D. (2003). IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 101: 1024-1029 [Abstract] [Full Text]  
• Nielsen, S. D., Jeppesen, D. L., Kolte, L., Clark, D. R., Sorensen, T. U., Dreves, A.-M., Ersboll, A. K., Ryder, L. P., Valerius, N. H., Nielsen, J. O. (2001). Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 98: 398-404 [Abstract] [Full Text]  
• Yu, X., Matsui, T., Otsuka, M., Sekine, T., Yamamoto, K., Nishioka, K., Kato, T. (2001). Anti-CD69 Autoantibodies Cross-React with Low Density Lipoprotein Receptor-Related Protein 2 in Systemic Autoimmune Diseases. J. Immunol. 166: 1360-1369 [Abstract] [Full Text]  
• Lim, L. C. L., Fiordalisi, M. N., Mantell, J. L., Schmitz, J. L., Folds, J. D. (1998). . CVI 5: 392-398 [Abstract]